Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sildenafil (Viagra) associated anterior ischemic optic neuropathy.

× No keyword cloud information.

18 in total

1. Thyroid eye disease: an unusual presentation.

Authors: J Shankar; C P Noonan; P Mathew; S Hanif
Journal: Br J Ophthalmol Date: 2003-07 Impact factor: 4.638

2. There have been inadequate warnings that erectile dysfunction drugs can cause blindness.

Authors: Sidney M Wolfe
Journal: MedGenMed Date: 2005-12-05

3. Can erectile dysfunction drug use lead to ischaemic optic neuropathy?

Authors: H D Pomeranz
Journal: Br J Ophthalmol Date: 2006-02 Impact factor: 4.638

4. Sildenafil induces retinal vasodilatation in healthy subjects.

Authors: Mona Pache; Peter Meyer; Christian Prünte; Selim Orgül; Ines Nuttli; Josef Flammer
Journal: Br J Ophthalmol Date: 2002-02 Impact factor: 4.638

5. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction.

Authors: G McGwin; M S Vaphiades; T A Hall; C Owsley
Journal: Br J Ophthalmol Date: 2006-02 Impact factor: 4.638

Review 6. Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Authors: Sharon A Huang; Janette D Lie
Journal: P T Date: 2013-07

7. ERG evaluation of daily, high-dose sildenafil usage.

Authors: Christopher I Zoumalan; Roham T Zamanian; Ramona L Doyle; Michael F Marmor
Journal: Doc Ophthalmol Date: 2008-09-26 Impact factor: 2.379

Review 8. Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors: Alan M Laties
Journal: Drug Saf Date: 2009 Impact factor: 5.606

Review 9. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?

Authors: Helen V Danesh-Meyer; Leonard A Levin
Journal: Br J Ophthalmol Date: 2007-11 Impact factor: 4.638

Review 10. Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors: R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal: Int J Clin Pract Date: 2009-08 Impact factor: 2.503